Brian Tanquilut

Q: What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of 75.18317853563975.

Q: What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of 11.368312084114786.

Jefferies | Healthcare

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector. Ranked #2097 out of 4553 analysts, they have issued 17 stock ratings with a success rate of 75.18% and an average return of 11.37%.

With 17 ratings to date, Brian Tanquilut is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 75.18% and an average return of 11.37%, highlighting promising potential as their track record develops further.

#2097

Out of 4553

Total Ratings

+75.18%

Success Rate

+11.37%

Average Return

Recent Ratings Analysis

ODD

Hold

Feb 25, 2026

Target

$64.00

Current

$14.74

Performance

0.00%

Brian Tanquilut rated ODD as Hold on Feb 25, 2026, setting a price target of 64. The Hold stance appears justified, as shares hovered around 14.74 with a 0.00% move.

EHAB

Hold

Feb 23, 2026

Target

$13.80

Current

$13.58

Performance

-0.15%

On Feb 23, 2026, EHAB was given a Hold rating by Brian Tanquilut, with a target price of 13.8. Market indecision, reflected in sideways trading near 13.58, supported the cautious call.

THC

Buy

Feb 12, 2026

Target

$265.00

Current

$237.04

Performance

2.06%

THC received a Buy rating from Brian Tanquilut on Feb 12, 2026, aiming for 265. Price action was muted, as shares hovered around 237.04 despite the bullish outlook.

HCA

Buy

Jan 28, 2026

Target

$590.00

Current

$540.57

Performance

10.04%

On Jan 28, 2026, Brian Tanquilut published a Buy outlook on HCA, with a target of 590. Shares gained 10.04%, underscoring the accuracy of the bullish outlook toward 590.

CHE

Hold

Jan 22, 2026

Target

$475.00

Current

$466.60

Performance

4.92%

Brian Tanquilut on Jan 22, 2026 assigned CHE a Hold rating, with a price target of 475. The Hold stance reflected consolidation, as shares held near 466.6.

ACHC

Hold

Jan 22, 2026

Target

$15.00

Current

$20.84

Performance

37.56%

On Jan 22, 2026, Brian Tanquilut reaffirmed ACHC with a Hold rating, targeting 15. Market strength beyond 20.84 went further than the conservative outlook suggested.

COR

Buy

Jan 22, 2026

Target

$440.00

Current

$363.03

Performance

3.00%

COR was rated Buy by Brian Tanquilut on Jan 22, 2026, with a price objective of 440. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

LMRI

Buy

Jan 05, 2026

Target

$23.00

Current

$14.70

Performance

-12.66%

On Jan 05, 2026, Brian Tanquilut initiated coverage on LMRI with a Buy rating and target of 23. The Buy call has yet to be validated as shares remain 8.30 away from the target.

AVAH

Buy

Oct 28, 2025

Target

$12.50

Current

$7.21

Performance

-26.50%

Brian Tanquilut issued a Buy recommendation for AVAH on Oct 28, 2025, price target set at 12.5. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

PNTG

Buy

Oct 24, 2025

Target

$30.00

Current

$33.09

Performance

31.10%

On Oct 24, 2025, PNTG was evaluated by Brian Tanquilut, who gave a Buy rating and target of 30. This case illustrates how a timely bullish rating can translate into tangible gains of 31.10%.

MCK

Buy

Oct 14, 2025

Target

$900.00

Current

$963.24

Performance

23.19%

Brian Tanquilut rated MCK as Buy on Oct 14, 2025, setting a price target of 900. The call has proven timely, with shares rising 23.19% toward the price target of 900.

CYH

Hold

Jul 24, 2025

Target

$3.00

Current

$3.64

Performance

25.52%

On Jul 24, 2025, CYH was given a Hold rating by Brian Tanquilut, with a target price of 3. The stock rallied from 3.64 to 3.64 after the Hold rating, surprising to the upside.

CVS

Buy

Jun 30, 2025

Target

$80.00

Current

$76.19

Performance

10.45%

CVS received a Buy rating from Brian Tanquilut on Jun 30, 2025, aiming for 80. Momentum has favored the Buy call, with shares climbing from 76.19 to 76.19, rewarding those who trusted the recommendation.

CAH

Buy

Feb 05, 2025

Target

$150.00

Current

$226.18

Performance

77.47%

On Feb 05, 2025, Brian Tanquilut published a Buy outlook on CAH, with a target of 150. Shares gained 77.47%, underscoring the accuracy of the bullish outlook toward 150.

OPCH

Buy

Jan 23, 2025

Target

$35.00

Current

$33.60

Performance

12.00%

Brian Tanquilut on Jan 23, 2025 assigned OPCH a Buy rating, with a price target of 35. The Buy call aligned well with market performance, producing a gain of 12.00%.

RDNT

Buy

Jan 15, 2025

Target

$80.00

Current

$70.01

Performance

13.39%

On Jan 15, 2025, Brian Tanquilut reaffirmed RDNT with a Buy rating, targeting 80. The recommendation was supported by strong follow-through as the stock rose from 70.01 to 70.01.

LH

Buy

Dec 10, 2024

Target

$275.00

Current

$282.78

Performance

20.57%

LH was rated Buy by Brian Tanquilut on Dec 10, 2024, with a price objective of 275. A bullish response from the market helped close the gap of -7.78 to the target.

BKD

Buy

Oct 16, 2024

Target

$8.00

Current

$15.12

Performance

126.35%

On Oct 16, 2024, Brian Tanquilut initiated coverage on BKD with a Buy rating and target of 8. The stock’s climb of 126.35% since the call highlights the foresight in the rating.

MODV

Hold

Sep 13, 2024

Target

$14.00

Current

$0.43

Performance

-96.94%

Brian Tanquilut issued a Hold recommendation for MODV on Sep 13, 2024, price target set at 14. Market action validated the conservative Hold outlook with shares at 0.4319.

Frequency Asked Questions

Who is Brian Tanquilut?

Brian Tanquilut is an analyst from Jefferies specializing in the Healthcare sector.

What is Brian Tanquilut's success rate?

Brian Tanquilut currently has a success rate of +75.18%.

How many ratings has Brian Tanquilut issued?

Brian Tanquilut has issued 17 stock ratings so far.

What is the average return of Brian Tanquilut's calls?

Their stock ratings have generated an average return of +11.37%.

What is Brian Tanquilut's ranking?

Brian Tanquilut is ranked #2097 out of 4553 analysts.

What types of ratings does Brian Tanquilut give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Tanquilut?

You can follow Brian Tanquilut by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Tanquilut?

Their latest rating was a Hold on ODD issued on 2026-02-25.